Company Search:
Advanced Search
Sponsored Links
Almirall SA Company Snapshot
Almirall SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Almirall SA with three other pharmaceutical manufacturers in Europe: Indivior Plc of the United Kingdom (2015 sales of £664.95 million [US$825.00 million] of which 100% was Buprenorphine Based Drugs), Pharmstandard OJSC of Russia (47.19 billion Russian Rubles [US$794.29 million] of which 97% was Pharmaceutical Products OTC), and Boiron SA which is based in France (607.80 million Euro [US$651.45 million] of which 51% was Non-Proprietary Homeopathic Medicines).

Sales Analysis. Almirall SA reported sales of 684.99 million Euro (US$734.17 million) for the year ending December of 2015. This represents a decrease of 12.9% versus 2014, when the company's sales were 786.40 million Euro. Contributing to the drop in overall sales was the 58.9% decline in Licenses, from 97.56 million Euro to 40.13 million Euro. There were also decreases in sales in Own Network (Spain) (down 16.3% to 472.05 million Euro) . However, these declines were partially offset by the increase in sales of Dermatology (up 35.4% to 150.01 million Euro) and Corporate (up 64.4% to 22.79 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Almirall SA
  Stock Performance Chart for Almirall SA
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 15.43
(Figures in Euro)
1 Week -2.3%   13 Weeks 7.7%  
4 Weeks 16.3%   52 Weeks -13.7%  
Almirall SA Key Data:
  Ticker: ALM Country: Spain
  Exchanges: BCN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 684,985,000
(Year Ending Jan 2016).
Employees: 1,889
  Currency: Euro Market Cap: 2,668,635,782
  Fiscal Yr Ends: December Shares Outstanding: 172,951,120
  Share Type: Accion Closely Held Shares: 115,697,775
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.